Also trades as: PME.AX (ASX) · $vol 31M
PMCUF OTC
Pro Medicus Limited
1W: -5.0%
1M: -11.9%
3M: -23.2%
YTD: -24.9%
1Y: -46.2%
3Y: +112.7%
5Y: +164.8%
$108.86
-5.19 (-4.55%)
Weekly Expected Move ±4.7%
$99
$104
$109
$114
$119
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$261M
+22.7% ▲
5Y CAGR: +30.9%
Gross Profit
$211M
-0.8% ▼
5Y CAGR: +35.2%
Operating Income
$196M
+24.3% ▲
5Y CAGR: +34.5%
Net Income
$265M
+130.0% ▲
5Y CAGR: +53.7%
EPS (Diluted)
$2.53
+130.0% ▲
5Y CAGR: +53.2%
EBITDA
$204M
+23.7% ▲
5Y CAGR: +32.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $93M | $125M | $162M | $213M | $261M |
| YoY Growth | +37.7% | +33.6% | +29.3% | +31.8% | +22.7% |
| Cost of Revenue | $465K | $33M | $301K | $309K | $50M |
| Gross Profit | $93M | $92M | $161M | $213M | $211M |
| Gross Margin | 99.4% | 74.0% | 99.8% | 99.9% | 80.7% |
| R&D Expenses | $7M | $7M | $8M | $0 | $0 |
| SG&A Expenses | $17M | $27M | $33M | $40M | $15M |
| Operating Expenses | $31M | $40M | $46M | $55M | $15M |
| Operating Income | $65M | $86M | $115M | $158M | $196M |
| Operating Margin | 69.5% | 69.0% | 71.1% | 74.0% | 74.9% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | $63M | $86M | $116M | $163M | $377M |
| Tax Expense | $19M | $25M | $34M | $48M | $112M |
| Net Income | $44M | $61M | $83M | $115M | $265M |
| Net Margin | 47.6% | 48.6% | 51.3% | 54.1% | 101.4% |
| EPS (Diluted) | $0.43 | $0.58 | $0.79 | $1.10 | $2.53 |
| EBITDA | $70M | $92M | $121M | $165M | $204M |
| Shares Outstanding | 105M | 105M | 105M | 105M | 105M |